As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened regulatory scrutiny, the role of the top pharmaceutical API manufacturer has taken on ...

ESTEVE CDMO, a global CDMO specializing in high-quality small-molecule APIs and pharmaceutical intermediates, began a $15.5 ...

South Korean contract manufacturer ST Pharm has sealed a supply contract worth $56 million to provide active pharmaceutical ingredients (APIs) for an oligonucleotide therapeutic developed by an ...

BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today reported strong growth in 2022 in both its ...

BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...

While solely API-focused players currently face increased competition, this transition is expected to strengthen long-term pricing power, improve margins, enhance compliance, and increase customer ...

KD Pharma, a Swiss API maker of omega-3 products, has snapped up a manufacturing site in Seal Sands, U.K., for an undisclosed price. The company said the acquisition will allow it to expand capacity ...

BUFFALO, N.Y., Jan. 23, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and ...

Vion Pharmaceuticals Extends Agreement With SAFC Pharma Partnership for Cloretazine API Manufacturing ST. LOUIS, March 21 -- SAFC, a member of the Sigma-Aldrich Group, continues its appointment as a ...

India Ratings (Ind-Ra) predicts a recovery in API prices for FY27, driven by India's Minimum Import Price (MIP) and China’s withdrawal of export VAT rebates.

BROOKLYN, New York, Oct. 14, 2020 (GLOBE NEWSWIRE) -- According to Global Market Estimates, the Indian API Market will grow rapidly at a CAGR of 8.57% during the 2020-2026 phase. The Indian drug ...

ESTEVE CDMO, the global pure-play contract development and manufacturing organization (CDMO) specializing in high-quality ...